• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

离心会影响液体活检肿瘤标志物的纯度。

Centrifugation affects the purity of liquid biopsy-based tumor biomarkers.

机构信息

Medical Cell BioPhysics, University of Twente, Enschede, the Netherlands.

Amsterdam UMC, University of Amsterdam, Laboratory of Experimental Clinical Chemistry, Amsterdam, the Netherlands.

出版信息

Cytometry A. 2018 Dec;93(12):1207-1212. doi: 10.1002/cyto.a.23641.

DOI:10.1002/cyto.a.23641
PMID:30551256
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6590195/
Abstract

Biomarkers in the blood of cancer patients include circulating tumor cells (CTCs), tumor-educated platelets (TEPs), tumor-derived extracellular vesicles (tdEVs), EV-associated miRNA (EV-miRNA), and circulating cell-free DNA (ccfDNA). Because the size and density of biomarkers differ, blood is centrifuged to isolate or concentrate the biomarker of interest. Here, we applied a model to estimate the effect of centrifugation on the purity of a biomarker according to published protocols. The model is based on the Stokes equation and was validated using polystyrene beads in buffer and plasma. Next, the model was applied to predict the biomarker behavior during centrifugation. The result was expressed as the recovery of CTCs, TEPs, tdEVs in three size ranges (1-8, 0.2-1, and 0.05-0.2 μm), EV-miRNA, and ccfDNA. Bead recovery was predicted with errors <18%. Most notable cofounders are the 22% contamination of 1-8 μm tdEVs for TEPs and the 8-82% contamination of <1 μm tdEVs for ccfDNA. A Stokes model can predict biomarker behavior in blood. None of the evaluated protocols produces a pure biomarker. Thus, care should be taken in the interpretation of obtained results, as, for example, results from TEPs may originate from co-isolated large tdEVs and ccfDNA may originate from DNA enclosed in <1 μm tdEVs. © 2018 The Authors. Cytometry Part A published by Wiley Periodicals, Inc. on behalf of International Society for Advancement of Cytometry.

摘要

癌症患者血液中的生物标志物包括循环肿瘤细胞(CTCs)、肿瘤衍生的血小板(TEPs)、肿瘤衍生的细胞外囊泡(tdEVs)、EV 相关 miRNA(EV-miRNA)和循环无细胞 DNA(ccfDNA)。由于生物标志物的大小和密度不同,需要对血液进行离心以分离或浓缩感兴趣的生物标志物。在这里,我们根据已发表的方案,应用模型来估计离心对生物标志物纯度的影响。该模型基于 Stokes 方程,并使用缓冲液和血浆中的聚苯乙烯珠进行了验证。接下来,该模型被应用于预测生物标志物在离心过程中的行为。结果以 CTCs、TEPs、tdEVs 在三个大小范围内(1-8、0.2-1 和 0.05-0.2μm)、EV-miRNA 和 ccfDNA 的回收率表示。珠子回收率的预测误差<18%。最显著的混杂因素是 1-8μm tdEVs 中 22%的 TEPs 污染和<1μm tdEVs 中 8-82%的 ccfDNA 污染。Stokes 模型可以预测血液中生物标志物的行为。评估的方案中没有一个能产生纯的生物标志物。因此,在解释获得的结果时应谨慎,例如,TEPs 的结果可能源自共同分离的大 tdEVs,而 ccfDNA 可能源自包裹在<1μm tdEVs 中的 DNA。2018 年,作者。细胞仪分析部分由 Wiley 期刊出版公司代表国际细胞分析促进协会出版。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d936/6590195/eba8c3d59fe9/CYTO-93-1207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d936/6590195/56e9e1a80c16/CYTO-93-1207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d936/6590195/eba8c3d59fe9/CYTO-93-1207-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d936/6590195/56e9e1a80c16/CYTO-93-1207-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d936/6590195/eba8c3d59fe9/CYTO-93-1207-g002.jpg

相似文献

1
Centrifugation affects the purity of liquid biopsy-based tumor biomarkers.离心会影响液体活检肿瘤标志物的纯度。
Cytometry A. 2018 Dec;93(12):1207-1212. doi: 10.1002/cyto.a.23641.
2
Tumor-educated platelets.肿瘤教育的血小板。
Blood. 2019 May 30;133(22):2359-2364. doi: 10.1182/blood-2018-12-852830. Epub 2019 Mar 4.
3
Pre-analytical factors affecting the establishment of a single tube assay for multiparameter liquid biopsy detection in melanoma patients.影响建立黑色素瘤患者多参数液体活检检测单管检测的分析前因素。
Mol Oncol. 2020 May;14(5):1001-1015. doi: 10.1002/1878-0261.12669. Epub 2020 Apr 4.
4
The Different Facets of Liquid Biopsy: A Kaleidoscopic View.液体活检的多重视角:千变万化。
Cold Spring Harb Perspect Med. 2020 Jun 1;10(6):a037333. doi: 10.1101/cshperspect.a037333.
5
Evaluation of the liquid biopsy for the detection of BRAFV600E mutation in metastatic melanoma patients.评估液体活检在转移性黑色素瘤患者 BRAFV600E 突变检测中的应用。
Cancer Biomark. 2019;26(3):271-279. doi: 10.3233/CBM-181647.
6
Tumor circulome in the liquid biopsies for cancer diagnosis and prognosis.液体活检中的肿瘤循环组学用于癌症的诊断和预后。
Theranostics. 2020 Mar 15;10(10):4544-4556. doi: 10.7150/thno.40532. eCollection 2020.
7
Tumor-educated platelets.肿瘤教育血小板。
Clin Chim Acta. 2024 Jan 1;552:117690. doi: 10.1016/j.cca.2023.117690. Epub 2023 Dec 6.
8
Emerging Nanotechnologies for Liquid Biopsy: The Detection of Circulating Tumor Cells and Extracellular Vesicles.新兴纳米技术在液体活检中的应用:循环肿瘤细胞和细胞外囊泡的检测。
Adv Mater. 2019 Nov;31(45):e1805344. doi: 10.1002/adma.201805344. Epub 2018 Dec 27.
9
Detection of extracellular vesicles in plasma and urine of prostate cancer patients by flow cytometry and surface plasmon resonance imaging.通过流式细胞术和表面等离子体共振成像检测前列腺癌患者血浆和尿液中的细胞外囊泡。
PLoS One. 2020 Jun 4;15(6):e0233443. doi: 10.1371/journal.pone.0233443. eCollection 2020.
10
A review of sensors for classification and subtype discrimination of cancer: Insights into circulating tumor cells and tumor-derived extracellular vesicles.用于癌症分类和亚型鉴别传感器的研究进展:循环肿瘤细胞和肿瘤来源细胞外囊泡的相关研究。
Anal Chim Acta. 2023 Mar 1;1244:340703. doi: 10.1016/j.aca.2022.340703. Epub 2022 Dec 10.

引用本文的文献

1
Emerging biomarkers for early cancer detection and diagnosis: challenges, innovations, and clinical perspectives.用于早期癌症检测和诊断的新兴生物标志物:挑战、创新与临床前景
Eur J Med Res. 2025 Aug 18;30(1):760. doi: 10.1186/s40001-025-03003-6.
2
Deciphering Platelets: Are They Cells or an Evolved Form of Extracellular Vesicles?解读血小板:它们是细胞还是细胞外囊泡的一种进化形式?
Circ Res. 2025 Feb 14;136(4):442-452. doi: 10.1161/CIRCRESAHA.124.324721. Epub 2025 Feb 13.
3
Clinical application of liquid biopsy in colorectal cancer: detection, prediction, and treatment monitoring.

本文引用的文献

1
Standardization of extracellular vesicle measurements by flow cytometry through vesicle diameter approximation.通过囊泡直径逼近实现流式细胞术对外泌体测量的标准化。
J Thromb Haemost. 2018 Jun;16(6):1236-1245. doi: 10.1111/jth.14009. Epub 2018 Apr 26.
2
Plasma vesicle miRNAs for therapy response monitoring in Hodgkin lymphoma patients.血浆囊泡 miRNA 可用于霍奇金淋巴瘤患者的治疗反应监测。
JCI Insight. 2016 Nov 17;1(19):e89631. doi: 10.1172/jci.insight.89631.
3
Isolation of exosomes by differential centrifugation: Theoretical analysis of a commonly used protocol.
液体活检在结直肠癌中的临床应用:检测、预测及治疗监测
Mol Cancer. 2024 Jul 16;23(1):145. doi: 10.1186/s12943-024-02063-2.
4
Clinical applications and challenges in the field of extracellular vesicles.细胞外囊泡领域的临床应用与挑战
Med Genet. 2023 Dec 5;35(4):251-258. doi: 10.1515/medgen-2023-2062. eCollection 2023 Dec.
5
Liquid biopsy techniques and lung cancer: diagnosis, monitoring and evaluation.液体活检技术与肺癌:诊断、监测与评估。
J Exp Clin Cancer Res. 2024 Apr 1;43(1):96. doi: 10.1186/s13046-024-03026-7.
6
Investigation of Plasma Cell-Free DNA and MiRNA in Cholangiocarcinoma and Opisthorchiasis Viverrini Patients.胆管癌和华支睾吸虫病患者血浆无细胞 DNA 和 miRNA 的研究。
Asian Pac J Cancer Prev. 2024 Mar 1;25(3):739-746. doi: 10.31557/APJCP.2024.25.3.739.
7
Storage Stability of Blood Samples for miRNAs in Glycosylated Extracellular Vesicles.糖基化细胞外囊泡中 miRNA 的血液样本储存稳定性。
Molecules. 2023 Dec 23;29(1):103. doi: 10.3390/molecules29010103.
8
Liquid biopsy: an examination of platelet RNA obtained from head and neck squamous cell carcinoma patients for predictive molecular tumor markers.液体活检:对头颈部鳞状细胞癌患者获取的血小板RNA进行检测以寻找预测性分子肿瘤标志物。
Explor Target Antitumor Ther. 2023;4(3):422-446. doi: 10.37349/etat.2023.00143. Epub 2023 Jun 30.
9
Research landscape of exosomes in platelets from 2000 to 2022: A bibliometric analysis.2000年至2022年血小板中外泌体的研究概况:一项文献计量分析。
Front Cardiovasc Med. 2022 Dec 20;9:1054816. doi: 10.3389/fcvm.2022.1054816. eCollection 2022.
10
Removal of platelets from blood plasma to improve the quality of extracellular vesicle research.从血浆中去除血小板以提高细胞外囊泡研究的质量。
J Thromb Haemost. 2022 Nov;20(11):2679-2685. doi: 10.1111/jth.15867. Epub 2022 Sep 14.
通过差速离心法分离外泌体:常用方案的理论分析
Sci Rep. 2015 Nov 30;5:17319. doi: 10.1038/srep17319.
4
RNA-Seq of Tumor-Educated Platelets Enables Blood-Based Pan-Cancer, Multiclass, and Molecular Pathway Cancer Diagnostics.肿瘤衍生血小板的RNA测序实现基于血液的泛癌、多类别和分子通路癌症诊断。
Cancer Cell. 2015 Nov 9;28(5):666-676. doi: 10.1016/j.ccell.2015.09.018. Epub 2015 Oct 29.
5
Single-step isolation of extracellular vesicles by size-exclusion chromatography.通过大小排阻色谱法一步分离细胞外囊泡。
J Extracell Vesicles. 2014 Sep 8;3. doi: 10.3402/jev.v3.23430. eCollection 2014.
6
The dynamic range of circulating tumor DNA in metastatic breast cancer.转移性乳腺癌中循环肿瘤DNA的动态范围。
Breast Cancer Res. 2014 Aug 9;16(4):421. doi: 10.1186/s13058-014-0421-y.
7
Measuring single cell mass, volume, and density with dual suspended microchannel resonators.使用双悬浮微通道谐振器测量单细胞的质量、体积和密度。
Lab Chip. 2014 Feb 7;14(3):569-576. doi: 10.1039/c3lc51022k.
8
Quantitative proteomics of extracellular vesicles derived from human primary and metastatic colorectal cancer cells.人原发和转移性结直肠癌细胞来源的细胞外囊泡的定量蛋白质组学研究。
J Extracell Vesicles. 2012 Sep 11;1. doi: 10.3402/jev.v1i0.18704. eCollection 2012.
9
Filter characteristics influencing circulating tumor cell enrichment from whole blood.影响全血中循环肿瘤细胞富集的滤器特性。
PLoS One. 2013 Apr 23;8(4):e61770. doi: 10.1371/journal.pone.0061770. Print 2013.
10
Proteome profiling of exosomes derived from human primary and metastatic colorectal cancer cells reveal differential expression of key metastatic factors and signal transduction components.人原发和转移性结直肠癌细胞来源的外泌体的蛋白质组谱分析揭示了关键转移因子和信号转导成分的差异表达。
Proteomics. 2013 May;13(10-11):1672-86. doi: 10.1002/pmic.201200562.